Epstein-Barr virus; Hodgkin's lymphoma; latent membrane protein-1 deletions; typing of EBV; polymerase chain reaction; in situ hybridization
Abstract :
[en] The association between Epstein-Barr virus (EBV) and classical Hodgkin's lymphoma (cHL) varies according to the geographic location. In this work we sought to characterize EBV involvement in a series of 111 cHL cases diagnosed in Belgium. The overall prevalence of EBV infection detected by in situ hybridization in Reed-Sternberg cells was 33%. EBV positivity correlated with older age at diagnosis (454 years; p = 0.01), mixed cellularity subtype (p = 0.000001), male gender (p = 0.004) and tended to be associated with higher clinical stage (III/IV; p = 0.02). The molecular features of the virus in EBV-positive cHL were studied by comparison with a series of reactive tonsils. A 30-bp deletion within the LMP-1 gene was in 15/28 (53.6%) EBV-positive cHL cases, and in 41.7% of reactive tonsil samples. This variant did not correlate with any clinical or pathological feature. The EBV strain was type A in all cHL and reactive samples.
IARC Cancer Base No. 5 (2001) GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, IARC Press, Lyon
Correa, P. and O'Conor, G. T. (1971) Epidemiologic patterns of Hodgkin's disease. Int J Cancer, 8, pp. 192-201.
Gutensohn, N. and Cole, P. (1981) Childhood social environment and Hodgkin's disease. N Engl J Med, 304, pp. 135-140.
Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E. and Magnus, K. (1989) Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med, 320, pp. 689-695.
Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S. and Muller-Lantzsch, N. (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA, 88, pp. 4766-4770.
Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M. and Young, L. S. (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet, 337, pp. 320-322.
Delsol, G., Brousset, P., Chittal, S. and Rigal-Huguet, F. (1992) Correlation of the expression of Epstein-Barr virus-latent membrane protein and in situ hybridization with biotinylated Bam HI-W probes in Hodgkin's disease. Am J Pathol, 140, pp. 247-253.
Khan, G., Norton, A. J. and Slavin, G. (1993) Epstein-Barr virus in Hodgkin disease relation to age and subtype. Cancer, 71, pp. 3124-3129.
Ambinder, R. F., Browning, P. J., Lorenzana, I., Leventhal, B. G., Cosenza, H. and Mann, R. B. (1993) Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood, 81, pp. 462-467.
Pinkus, G. S., Lones, M., Shintaku, I. P. and Said, J. W. (1994) Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease. Mod Pathol, 7, pp. 456-461.
Hayashi, K., Chen, W. G., Chen, Y. Y., Bacchi, M. M., Bachi, C. E. and Alvarenga, M. (1997) Deletion of Epstein-Barr virus latent membrane protein-1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: High frequency of a 30-bp deletion. Hum Pathol, 28, pp. 1408-1414.
Belkaid, M. L., Briere, J., Djebbara, Z., Beldjord, K., Andrieu, J. M. and Colonna, P. (1995) Comparison of Epstein-Barr virus markers in Reed-sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country. Leuk Lymphoma, 17, pp. 163-168.
Enblad, G., Sandvej, K., Sundstrom, C., Pallesen, G. and Glimelius, B. (1999) Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncol, 38, pp. 425-429.
Armstrong, A. A., Alexander, F. E., Cartwright, R., Angus, B., Krajewski, A. S. and Wright, D. H. (1998) Epstein-Barr virus and Hodgkin's disease: Further evidence for the three disease hypothesis. Leukemia, 12, pp. 1272-1276.
Herbst, H., Steinbrecher, E., Niedobitek, G., Young, L. S., Brooks, L. and Muller-Lantzsch, N. (1992) Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood, 80, pp. 484-491.
Hummel, M., Anagnostopoulos, I., Dallenbach, F., Korbjuhn, P., Dimmler, C. and Stein, H. (1992) EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: Expression and cellular localization of EBV gene products. Br J Haematol, 82, pp. 689-694.
Niedobitek, G., Rowlands, D. C., Young, L. S., Herbst, H., Williams, A. and Hall, P. (1993) Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein-Barr virus infection. J Pathol, 169, pp. 207-212.
Jarrett, A. F., Armstrong, A. A. and Alexander, E. (1996) Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol, 7, pp. 5-10.
Macak, J., Habanec, B. and Fabian, P. (2000) Detection of Epstein-Barr virus in Hodgkin's lymphoma (patients in the Czech Republic). Neoplasma, 47, pp. 156-161.
Leoncini, L., Spina, D., Nyong'o, A., Abinya, O., Minacci, C. and Disanto, A. (1996) Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer, 65, pp. 781-784.
Chang, K. L., Albujar, P. F., Chen, Y. Y., Johnson, R. M. and Weiss, L. M. (1993) High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood, 81, pp. 496-501.
Zarate-Osorno, A., Roman, L. N., Kingma, D. W., Meneses-Garcia, A. and Jaffe, E. S. (1995) Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer, 75, pp. 1360-1366.
Dirnhofer, S., Angeles-Angeles, A., Ortiz-Hidalgo, C., Reyes, E., Gredler, E. and Krugmann, J. (1999) High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol, 30, pp. 781-787.
Weinreb, M., Day, P. J., Niggli, F., Green, E. K., Nyong'o, A. O. and Othieno-Abinya, N. A. (1996) The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Blood, 87, pp. 3828-3836.
Kusuda, M., Toriyama, K., Kamidgo, N. O. and Itakura, H. (1998) A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenia and Nagasaki, Japan. Am J Trop Med, 59, pp. 801-807.
Korbi, S., Trimeche, M., Sriha, B., Yacoubi, M. T., Hmissa, S. and Mokni, M. (2002) Epstein-Barr virus in Hodgkin's disease: The example of central Tunisia. Ann Pathol, 22, pp. 96-101.
Weiss, L. M., Movahed, L. A., Warnke, R. A. and Sklar, J. (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med, 320, pp. 502-506.
Weiss, L., Strickler, J. G., Warnke, P. A., Purtilo, D. T. and Sklar, J. (1987) Epstein-Barr virus-DNA, in tissus of Hodgkin's disease. Am J of Pathol, 129, pp. 86-91.
Vasef, M. A., Kamel, O. W., Chen, Y. Y., Medeiros, L. J. and Weiss, L. M. (1995) Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol, 147, pp. 1408-1415.
Wang, D., Liebowitz, D. and Kieff, E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, pp. 831-840.
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F. and Longnecker, R. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 products infected B-cells from programmed cell death. Cell, 65, pp. 1107-1115.
Chen, M. L., Tsai, C. N., Liang, C. L., Shu, C. H., Huang, C. R. and Sulitzeanu, D. (1992) Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene, 7, pp. 2131-2140.
Knecht, H., Bachmann, E., Brousset, P., Sandvej, K., Nadal, D. and Bachmann, F. (1993) Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood, 82, pp. 2937-2942.
Sandvej, K., Peh, S. C., Andresen, B. S. and Pallesen, G. (1994) Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood, 84, pp. 4053-4060.
Santon, A., Martin, C., Manzanal, A. I., Preciado, M. V. and Bellas, C. (1998) Paediatric Hodgkin's disease in Spain: Association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections. Br J Haematol, 103, pp. 129-136.
Kingma, D. W., Weiss, W. B., Jaffe, E. S., Kumar, S., Frekko, K. and Raffeld, M. (1996) Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood, 88, pp. 242-251.
Bellas, C., Santon, A., Manzanal, A., Campo, E., Martin, C. and Acevedo, A. (1996) Pathological, immunological, and molecular features of Hodgkin's disease association with HIV infection. Comparison with ordinary Hodgkin's disease. Am J Surg Pathol, 20, pp. 1520-1524.
Dolcetti, R., Zancai, P., De Re, P., Gloghini, A., Bigoni, B. and Pivetta, B. (1997) Epstein-Barr virus strains with latent membrane protein-1 deletions: Prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood, 89, pp. 1723-1731.
Trimeche, M., Korbi, S., Ziadi, S., Amara, K., Boniver, J. and de Leval, L. (2005) Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: Prevalence of the LMP1 oncogene deletions and A and B viruses strains. Ann Biol Clin, 63, pp. 193-199.
Dolcetti, R., Quaia, M., Gloghini, A., De Re, V., Zancai, P. and Cariati, R. (1999) Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease. Int J Cancer, 80, pp. 240-249.
Rickinson, A. B., Young, L. S. and Rowe, M. (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol, 61, pp. 1310-1317.
Boyle, M. J., Vasak, E., Tschuchnigg, M., Turner, J. J., Sculley, T. and Penny, R. (1993) Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: Association between B-type EBV and immunocompromise. Blood, 81, pp. 468-474.
Boyle, M. J., Sewell, W. A., Sculley, T. B., Apolloni, A., Turner, J. J. and Swanson, C. E. (1991) Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood, 78, pp. 3004-3011.
Jaffe, E. S., Harris, N. L., Stein, H. and Vardiman, J. W. (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, p. 352. IARC Press, Lyon
Lukes, R. J. and Butler, J. J. (1966) The pathology and nomenclature of Hodgkin's disease. Cancer Research, 26, pp. 1063-1083.
Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithiers, D. W. and Tubiana, M. (1966) Report of the committee on Hodgkin's disease staging. Cancer Res, 31, pp. 1860-1861.
de Leval, L., Vivario, M., De Prijck, B., Zhou, Y., Boniver, J. and Harris, N. L. (2004) Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. Am J Surg Pathol, 28, pp. 679-686.
Edinger, J. W., Bonneville, M., Scotet, E., Houssaint, E., Schumacher, H. R. and Posnett, D. N. (1999) EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J Immunol, 162, pp. 3694-3701.
Tacyildiz, N., Cavdar, A. O., Ertem, U., Oksal, A., Kutluay, L. and Uluoglu, O. (1998) Unusually high frequency of a 69-bp deletion within the carboxy terminus of the LMP-1 oncogene of Epstein-Barr virus detected in Burkitt's lymphoma of Turkish children. Leukemia, 12, pp. 1796-1805.
Lin, J. -C., Lin, S. C., De, B. K., Chan, W. P. and Evatt, B. L. (1993) Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): Predominance of type A virus associated with Hodgkin's disease. Blood, 81, pp. 3372-3381.
Weinreb, M., Day, P. J., Murray, P. G., Raafat, F., Crocker, J. and Parkes, S. E. (1992) Epstein-Barr virus (EBV) and Hodgkin's disease in children: Incidence of EBV latent membrane protein in malignant cells. J Pathol, 168, pp. 365-369.
Brousset, P., Rochaix, P., Chittal, S., Rubie, H., Robert, A. and Delsol, G. (1993) High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology, 23, pp. 189-191.
Murray, P. G., Young, L. S., Rowe, M. and Crocker, J. (1992) Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol, 166, pp. 1-5.
Armstrong, A. A., Alexander, F. E., Paes, R. P., Morad, N. A., Gallagher, A. and Krajewski, A. S. (1993) Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol, 142, pp. 1683-1688.
Glavina-Durdov, M., Jakic-Razumovic, J., Capkun, V. and Murray, P. (2001) Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer, 84, pp. 1227-1234.
Stark, G. L., Wood, K. M., Jack, F., Angus, B., Proctor, S. J. and Taylor, P. R. (2002) Northern Region Lymphoma Group. Hodgkin's disease in the elderly: A population-based study. Br J Haematol, 119, pp. 432-440.
Flavell, K. J., Billingham, L. J., Biddulph, J. P., Gray, L., Flavell, J. R. and Constandinou, C. M. (2003) The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease. Ann Oncol, 14, pp. 282-290.
Vestlev, P. M., Pallesen, G., Sandvej, K., Hamilton-Dutoit, S. J. and Bendtzen, S. M. (1992) Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer, 50, pp. 670-671.
Lauritzen, A. F., Hording, U. and Nielsen, H. W. (1994) Epstein-Barr virus and Hodgkin's disease: A comparative immunological, in situ hybridization, and polymerase chain reaction study. APMIS, 102, pp. 495-500.
Kanavaros, P., Jiwa, M., van der Valk, P., Walboomers, J., Horstman, A. and Meijer, C. J. (1993) Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Hum Pathol, 24, pp. 725-729.
van Gorp, J., Jacobse, K. C., Broekhuizen, R., Alers, J., Tweel, J G van den and de Weger, R. A. (1994) Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease. J Clin Pathol, 47, pp. 29-32.
Morente, M. M., Piris, M. A., Abraira, V., Acevedo, A., Aguilera, B. and Bellas, C. (1997) Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood, 90, pp. 2429-2436.
Kanavaros, P., Sakalidou, A., Tzardi, M., Darivianaki, K., Delides, G. and Kazlaris, E. (1994) Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin's disease arising in childhood. Pathol Res Pract, 190, pp. 1026-1030.
Gulley, M. L., Glaser, S. L., Craig, F. E., Borowitz, M., Mann, R. B. and Shema, S. J. (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol, 117, pp. 259-267.
Krugmann, J., Tzankov, A., Gschwendtner, A., Fischhofer, M., Greil, R. and Fend, F. (2003) Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: A single-institution study. Mod Pathol, 16, pp. 566-573.
Glaser, S. L., Lin, R. J., Stewart, S. L., Ambinder, R. F., Jarrett, R. F. and Brousset, P. (1997) Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer, 70, pp. 375-382.
Jarrett, R. F., Gallagher, A., Jones, D. B., Alexander, F. E., Krajewski, A. S. and Kelsey, A. (1991) Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age. J Clin Pathol, 44, pp. 844-848.
Jarrett, R. F. and MacKenzie, J. (1999) Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease. Semin Hematol, 36, pp. 260-269.
Lamy, M. E., Favart, A. M., Cornu, C., Mendez, M., Segas, M. and Burtonboy, G. (1982) Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique: Serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis-seroepidemiology of EBV in Belgium based on 5178 sera from patients. Acta Clin Belg, 37, pp. 281-298.
Huh, J., Park, C., Juhng, S., Kim, C. E., Poppema, S. and Kim, C. (1996) A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer, 77, pp. 949-955.
Murray, P. G., Billingham, L. J., Hassen, H. T., Flavell, J. R., Nelson, P. N. and Scott, K. (1999) Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood, 94, pp. 442-447.
Jarrett, R. F., Stark, G. L., White, J., Angus, B., Alexander, F. E. and Krajewski, A. S. (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classical Hodgkin lymphoma: A population-based study. Blood, 106, pp. 2444-2451.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
